✦ LIBER ✦

Prospective study of high-risk,BRCA1/2-mutation negative women: the‘negative study’

✍ Scribed by Kotsopoulos, Joanne; Metcalfe, Kelly; Alston, Jill; Nikitina, Dina; Ginsburg, Ophira; Eisen, Andrea; Demsky, Rochelle; Akbari, Mohammad; Zbuk, Kevin; Narod, Steven A

Book ID: 125398883
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 282 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective study of breast cancer risk

Prospective study of breast cancer risk for mutation negative women fromBRCA1orBRCA2mutation positive families

✍ S. L. Harvey; R. L. Milne; S. A. McLachlan; M. L. Friedlander; K. E. Birch; P. W 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 194 KB

The risk of endometrial cancer in women

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study

✍ Mario E. Beiner; Amy Finch; Barry Rosen; Jan Lubinski; Pal Moller; Parviz Ghadir 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 110 KB

BRCA mutation-negative women from heredi

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience

✍ Alexis D. Bakos; Sadie P. Hutson; Jennifer T. Loud; June A. Peters; Ruthann M. G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Parental origin of mutation and the risk

Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

✍ Senst, N; Llacuachaqui, M; Lubinski, J; Lynch, H; Armel, S; Neuhausen, S; Ghadir 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

No mutations in the XRCC2 gene in BRCA1/

No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families

✍ Raquel Rodríguez-López; Ana Osorio; Luis Sánchez-Pulido; Miguel de la Hoya; Alic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB

About 5-10% of breast cancer cases are hereditary and attributable to mutations in several susceptibility genes from which to date only 2 have been identified: BRCA1 (17q21) and BRCA2 (13q12). However, the BRCA genes only explain about 30% of familial breast/ovarian cancer, suggesting the existence

Risk of cancer in BRCA1 and BRCA2 mutati

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

✍ Hannaleena Eerola; Eero Pukkala; Seppo Pyrhönen; Carl Blomqvist; Risto Sankila; 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 118 KB